TrialTargeted oncology2024

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.

Toshihiko Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.